Status:
RECRUITING
Comparison of 5.0T and 3.0T Biparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer
Lead Sponsor:
Anhui Provincial Hospital
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Brief Summary
The goal of this observational study is to compare 5.0T and 3.0T biparametric magnetic resonance imaging in the diagnosis of prostate cancer. The main aims of this study are: * Compare the diagnostic...
Detailed Description
The methods currently recommended by the guidelines for early diagnosis of prostate cancer mainly include rectal examination, serum prostate-specific antigen detection, transrectal prostate ultrasound...
Eligibility Criteria
Inclusion
- The patient has at least one indication for prostate biopsy (Chinese expert consensus on prostate biopsy (2022 edition) );
- The primary prostate cancer has no other cancer history;
- The 3.0TbpMRI examination was completed, and the images were clear and accessible;
- The 5.0TbpMRI examination was further completed, and the images were clear and accessible;
- The patient fully understands the relevant content of the study and voluntarily signs the informed consent.
Exclusion
- The patient has contraindications to MRI examination, such as metal plates and heart stents in the body;
- The patient does not have an indication for prostate biopsy or refuses biopsy;
- The patient has contraindications to prostate biopsy;
- 3.0T MRI considers that the patient has multiple lymph node or bone metastases;
- The patient has undergone other prostatic surgery in the past;
- The patient is unable to cooperate, has communication barriers, or refuses to sign the informed consent form.
Key Trial Info
Start Date :
October 8 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06612047
Start Date
October 8 2024
End Date
December 31 2026
Last Update
February 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Urology, The First Affiliated Hospital of USTC
Hefei, Anhui, China, 230001